Study Guide for Pharmacology : A Patient-Centered Nursing Process Approach /: A Patient-Centered Nursing Process Approach. (2020)
- Record Type:
- Book
- Title:
- Study Guide for Pharmacology : A Patient-Centered Nursing Process Approach /: A Patient-Centered Nursing Process Approach. (2020)
- Main Title:
- Study Guide for Pharmacology : A Patient-Centered Nursing Process Approach
- Further Information:
- Note: Linda E. McCuistion, Kathleen DiMaggio, Mary Beth Winton, Jennifer J. Yeager.
- Authors:
- McCuistion, Linda E
DiMaggio, Kathleen
Winton, Mary Beth
Yeager, Jennifer J - Contents:
- Section I: Introduction to Pharmacology ; 1.The Nursing Process and Patient-Centered Care; 2.Drug Development and Ethical Considerations; 3.Pharmacokinetics and Pharmacodynamics; 4.Pharmacogenetics; 5.Complementary and Alternative Therapies; 6.Pediatric Considerations; 7.Older Adult Considerations; 8.Drugs in Substance Use Disorder; Section II: Pharmacotherapy and Drug Administration ; 9.Safety and Quality; 10.Drug Administration; 11.Drug Calculations; Section III: Maintenance of Homeostasis ; 12.Fluid Volume and Electrolytes; 13.Vitamin and Mineral Replacement; 14.Nutritional Support; Section IV: Autonomic Nervous System Drugs ; 15.Adrenergic Agonists and Antagonists; 16.Cholinergic Agonists and Antagonists; Section V: Central and Peripheral Nervous System Drugs ; 17.Stimulants; 18.Depressants; 19.Antiseizure Drugs; 20.Drugs for Parkinsonism and Alzheimer’s Disease; 21.Drugs for Neuromuscular Disorders and Muscle Spasms; Section VI: Mental and Behavioral Health Drugs ; 22.Antipsychotics and Anxiolytics; 23.Antidepressants and Mood Stabilizers; Section VII: Pain and Inflammation Management Drugs ; 24.Antiinflammatories; 25.Analgesics; Section VIII: Antimicrobial Drugs ; 26.Antibacterials; 1.Section A: Penicillins and Cephalosporins; 2.Section B: Macrolides and Tetracyclines; 3.Section C: Aminoglycosides and Fluoroquinolones; 4.Section D: Sulfonamides and Metronidazole; 27.Antituberculars, Antifungals, and Antivirals; 28.Antimalarials, Anthelmintics, and Peptides; Section IX:Section I: Introduction to Pharmacology ; 1.The Nursing Process and Patient-Centered Care; 2.Drug Development and Ethical Considerations; 3.Pharmacokinetics and Pharmacodynamics; 4.Pharmacogenetics; 5.Complementary and Alternative Therapies; 6.Pediatric Considerations; 7.Older Adult Considerations; 8.Drugs in Substance Use Disorder; Section II: Pharmacotherapy and Drug Administration ; 9.Safety and Quality; 10.Drug Administration; 11.Drug Calculations; Section III: Maintenance of Homeostasis ; 12.Fluid Volume and Electrolytes; 13.Vitamin and Mineral Replacement; 14.Nutritional Support; Section IV: Autonomic Nervous System Drugs ; 15.Adrenergic Agonists and Antagonists; 16.Cholinergic Agonists and Antagonists; Section V: Central and Peripheral Nervous System Drugs ; 17.Stimulants; 18.Depressants; 19.Antiseizure Drugs; 20.Drugs for Parkinsonism and Alzheimer’s Disease; 21.Drugs for Neuromuscular Disorders and Muscle Spasms; Section VI: Mental and Behavioral Health Drugs ; 22.Antipsychotics and Anxiolytics; 23.Antidepressants and Mood Stabilizers; Section VII: Pain and Inflammation Management Drugs ; 24.Antiinflammatories; 25.Analgesics; Section VIII: Antimicrobial Drugs ; 26.Antibacterials; 1.Section A: Penicillins and Cephalosporins; 2.Section B: Macrolides and Tetracyclines; 3.Section C: Aminoglycosides and Fluoroquinolones; 4.Section D: Sulfonamides and Metronidazole; 27.Antituberculars, Antifungals, and Antivirals; 28.Antimalarials, Anthelmintics, and Peptides; Section IX: Immunologic Drugs ; 29.HIV- and AIDS-Related Drugs; 30.Transplant Drugs; 31.Vaccines; Section X: Antineoplastics and Biologic Response Modifiers ; 32.Anticancer Drugs; 33.Targeted Therapies to Treat Cancer; 34.Biologic Response Modifiers; Section XI: Respiratory Drugs ; 35.Upper Respiratory Disorders; 36.Lower Respiratory Disorders; Section XII: Cardiovascular Drugs ; 37.Cardiac Glycosides, Antianginals, and Antidysrhythmics; 38.Diuretics; 39.Antihypertensives; 1.Section A: Beta Blockers; 2.Section B: Alpha Blockers; 3.Section C: Drugs Affecting RAAS; 4.Section D: Calcium Channel Blockers; 40.Anticoagulants, Antiplatelets, and Thrombolytics; 41.Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow; Section XIII: Gastrointestinal Drugs ; 42.Gastrointestinal Tract Disorders; 43.Antiulcer Drugs; Section XIV: Eye, Ear, and Skin Drugs ; 44.Eye and Ear Disorders; 45.Dermatologic Disorders; Section XV: Endocrine Drugs ; 46.Pituitary, Thyroid, Parathyroid, and Adrenal Disorders; 47.Antidiabetics; Section XVI: Renal and Urologic Drugs ; 48.Urinary Disorders; Section XVII: Reproductive and Gender-Related Drugs ; 49.Pregnancy and Preterm Labor; 50.Labor, Delivery, and Postpartum; 51.Neonatal and Newborn; 52.Women’s Reproductive Health; 53.Men’s Health and Reproductive Disorders; 54.Sexually Transmitted Infections; Section XVIII: Emergency Drugs ; 55.Adult and Pediatric Emergency Drugs; Answer Key … (more)
- Edition:
- 10th
- Publisher Details:
- Elsevier
- Publication Date:
- 2020
- Extent:
- 1 online resource (288 pages)
- Languages:
- English
- ISBNs:
- 9780323759069
0323759068 - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.661817
- Ingest File:
- 08_010.xml